Philippe Toussaint
Lyon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Nivolumab in combination with ipilimumab versus capecitabine as post-operative treatment for triple negative breast cancer patients with residual disease after neoadjuvant chemotherapy: a multicentre, randomized, open-label phase II trial - BREASTIMMUNE-03.
Journal: Breast (Edinburgh, Scotland)
Published: August 26, 2025
Compression therapy with surgical gloves compared to cold therapy with frozen gloves in preventing paclitaxel-induced peripheral neuropathy: Results from the prospective ELEGANT trial in patients with breast cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 15, 2025
Mucinous ovarian carcinoma: Impact of ovarian stimulation, hormonal contraception, and hormone replacement therapy.
Journal: European journal of obstetrics, gynecology, and reproductive biology
Published: October 14, 2024
Real-World Data on Olaparib in Relapsed BRCA-mutated Ovarian Cancer: A Multicenter GINECO RETROLA Cohort Study.
Journal: Anticancer research
Published: September 05, 2022
Alterations in Homologous Recombination-Related Genes and Distinct Platinum Response in Metastatic Triple-Negative Breast Cancers: A Subgroup Analysis of the ProfiLER-01 Trial.
Journal: Journal of personalized medicine
Published: July 31, 2022
Real-World Experience of Bevacizumab as First-Line Treatment for Ovarian Cancer: The GINECO ENCOURAGE Cohort of 468 French Patients.
Journal: Frontiers in pharmacology
Published: May 19, 2021
New therapeutic strategies in HER2-positive breast cancer
Journal: Bulletin du cancer
Published: October 23, 2020
Chemotherapy for recurrent/metastatic head and neck cancers.
Journal: Anti-cancer drugs
Published: February 07, 2017
Chemotherapy for localized head and neck squamous cell cancers.
Journal: Anti-cancer drugs
Published: January 31, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026